273 related articles for article (PubMed ID: 29932988)
1. Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.
Vecchi L; Alves Pereira Zóia M; Goss Santos T; de Oliveira Beserra A; Colaço Ramos CM; França Matias Colombo B; Paiva Maia YC; Piana de Andrade V; Teixeira Soares Mota S; Gonçalves de Araújo T; Van Petten de Vasconcelos Azevedo F; Soares FA; Oliani SM; Goulart LR
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1368-1382. PubMed ID: 29932988
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 Signaling in Triple Negative Breast Cancer Cells Elicits the Annexin A1/Formyl Peptide Receptor 1 Axis and Affects the Tumor Microenvironment.
Vecchi L; Mota STS; Zóia MAP; Martins IC; de Souza JB; Santos TG; Beserra AO; de Andrade VP; Goulart LR; Araújo TG
Cells; 2022 May; 11(10):. PubMed ID: 35626741
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis to brain results in recruitment and activation of microglia through annexin-A1/formyl peptide receptor signaling.
Foo SL; Sachaphibulkij K; Lee CLY; Yap GLR; Cui J; Arumugam T; Lim LHK
Breast Cancer Res; 2022 Apr; 24(1):25. PubMed ID: 35382852
[TBL] [Abstract][Full Text] [Related]
4. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2.
Khau T; Langenbach SY; Schuliga M; Harris T; Johnstone CN; Anderson RL; Stewart AG
FASEB J; 2011 Feb; 25(2):483-96. PubMed ID: 20930115
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1.
Zóia MAP; Azevedo FVP; Vecchi L; Mota STS; Rodovalho VR; Cordeiro AO; Correia LIV; Silva ACA; Ávila VMR; Araújo TG; Goulart LR
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884823
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
8. Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer.
Okano M; Kumamoto K; Saito M; Onozawa H; Saito K; Abe N; Ohtake T; Takenoshita S
Oncol Rep; 2015 Mar; 33(3):1064-70. PubMed ID: 25592491
[TBL] [Abstract][Full Text] [Related]
9. Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer.
Bai F; Zhang P; Fu Y; Chen H; Zhang M; Huang Q; Li D; Li B; Wu K
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32300050
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias.
Takaoka RTC; Sertório ND; Magalini LPJ; Dos Santos LM; Souza HR; Iyomasa-Pilon MM; Possebon L; Costa SS; Girol AP
Pathol Res Pract; 2018 Feb; 214(2):181-186. PubMed ID: 29254791
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1/Formyl Peptide Receptor Pathway Controls Uterine Receptivity to the Blastocyst.
Hebeda CB; Sandri S; Benis CM; Paula-Silva M; Loiola RA; Reutelingsperger C; Perretti M; Farsky SHP
Cells; 2020 May; 9(5):. PubMed ID: 32403233
[TBL] [Abstract][Full Text] [Related]
12. PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.
Chen L; Yuan Y; Kar S; Kanchi MM; Arora S; Kim JE; Koh PF; Yousef E; Samy RP; Shanmugam MK; Tan TZ; Shin SW; Arfuso F; Shen HM; Yang H; Goh BC; Park JI; Gaboury L; Lobie PE; Sethi G; Lim LHK; Kumar AP
Mol Cancer Ther; 2017 Nov; 16(11):2528-2542. PubMed ID: 29021293
[TBL] [Abstract][Full Text] [Related]
13. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
[TBL] [Abstract][Full Text] [Related]
14. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
Okano M; Oshi M; Butash AL; Katsuta E; Tachibana K; Saito K; Okayama H; Peng X; Yan L; Kono K; Ohtake T; Takabe K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461932
[TBL] [Abstract][Full Text] [Related]
15. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway.
Cheng TY; Wu MS; Lin JT; Lin MT; Shun CT; Huang HY; Hua KT; Kuo ML
Cancer; 2012 Dec; 118(23):5757-67. PubMed ID: 22736399
[TBL] [Abstract][Full Text] [Related]
16. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
[TBL] [Abstract][Full Text] [Related]
17. The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.
Snapkov I; Öqvist CO; Figenschau Y; Kogner P; Johnsen JI; Sveinbjørnsson B
BMC Cancer; 2016 Jul; 16():490. PubMed ID: 27432059
[TBL] [Abstract][Full Text] [Related]
18. The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells.
Kang H; Ko J; Jang SW
Biochem Biophys Res Commun; 2012 Jun; 423(1):188-94. PubMed ID: 22640735
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
[TBL] [Abstract][Full Text] [Related]
20. Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway.
Belvedere R; Bizzarro V; Forte G; Dal Piaz F; Parente L; Petrella A
Sci Rep; 2016 Jul; 6():29660. PubMed ID: 27412958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
